James Emmett Young - Chief Financial Officer at TriSalus Life Sciences, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Issuer Symbol
TLSI, TLSIW on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by James Emmett Young since 12 Mar 2025

Holdings reported by James Emmett Young for TriSalus Life Sciences, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 49,663 $257,254 $5.18 19 May 2025 Direct
Common Stock 30,000 $171,600 $5.72 19 May 2025 By Kathleen A. Young Living Trust
Employee Stock Option (right to buy) 75,000 27 Jan 2025 Direct Common Stock

Transactions reported by James Emmett Young for TriSalus Life Sciences, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.